Skip to main content
. 2022 Apr 29;80:104037. doi: 10.1016/j.ebiom.2022.104037

Table 1.

Demographical clinical characteristics of all study participants.

Value for groupa
HIV- HIV+, IRs HIV+, INRs p value (two HIV+ groups)c
Number of participants 60 31 40
Sex (Male/Female) 42/18 23/8 39/1
Age (yr) 37.5 46 52 0.0011
(31-55.75) (35-53) (45.25-60.75)
Race (AA/W/Others)b 15/38/7 17/14/0 4/30/2006 NA
CD4+ T cell counts (Cells/μl) 707 253 <0.0001
(545-958) (212.5-310.8)
Nadir CD4+ T cell counts 207 59.5 <0.0001
(50-353) (23-128.8)
Viral load pre-ARTd 37300 57307 0.78
(31336-119535) (48816-60202)
Time from diagnosis to ART (year)d 7 10 0.196
(4-12) (6-14)
Duration of ARTd 5 7.5 0.0006
(4-6) (5-9.75)
Duration of undetectable virusd 4 7 0.0023
(3-6) (4-8)
Viral blipsd 1 1 0.4
(0-4) (0-2)
a

Data are medians (interquartile ranges).

b

AA: African American; W: White; Others: Mixed Ethnicity/Multiracial and Hispanic/Latino.

c

Fisher's exact test or Mann-Whitney's U test (unpaired) were used.

d

Descriptive statistics have removed unknown or unavailable data (NA), details see Supplementary Table 1.